Compliance Online, Philadelphia, PA
2016-10-06
Description: Pharmaceutical and biotechnology companies across the globe face unprecedented challenges in the dynamically changing clinical, regulatory and business landscape. Aging populations, chronic diseases, technology and treatment advances are expected to spur health sector growth in 2016. As we approach 2016, it is imperative that leaders in the pharma space understand the trends and shifts happening around them.
This summit will provide a venue for industry experts, policymakers, manufacturers, inventors and clinician to discuss and debate these challenges as well as explore new strategies and opportunities for growth. This event therefore gives professionals – whether they are new entrants in the field or middle management or veterans – to interact with the leading minds in the industry about the current state of laws and technology and government oversight and more.
The panel discussions, debates, workshops and exhibitions will also throw light on the direction the industry will take in the future – making it all the more important for today’s pharma professionals to actively take part in this Summit.
Format:
ComplianceOnline Pharma Summit 2016 - Risk Control & Compliance will include the following:
Keynote Addresses Leading pharma/biotech experts and company executives give their view of the current issues and future challenges in the industry.
Panel Discussions Panels comprising some of the well-known thinkers and innovators in biotech/pharma technology, regulatory compliance and quality will discuss and debate the hottest issues that are affecting the industry. Attendees will be able to interact with panel members during these debates and get unparalleled insight into the state of the industry.
Multiple Tracks The Summit will have event tracks dedicated to topics affecting each division/segment of the biotech and pharmaceutical industry.
Focused Workshops Expert-led workshops that will help those pharma professionals starting out in their careers and even more senior professionals who need to brush up on new technologies, regulations, processes and more.
Networking Sessions Attendees will get to interact with and meet the leading decision makers in the industry in order to exchange ideas, discuss business opportunities and share strategies in focused, small groups.
Exhibitors' Stalls A unique opportunity for biotech and pharma companies both big and small to market their offerings and identify new business opportunities.
Note: Use coupon code NB5SQH8N and get 10% off on registration.
For Registration:
|
|
|
Invited Speakers:
|
|
Featured speakers invited so far: FDA Professionals Robert Popovian, Sr. Director, US Government Relations, Pfizer Pharmaceuticals Rick Williams, (Partner, Newport Board Group New England Practice, Chairman of Point Care Technology, Board Member of Amorphex Therapeutics) John Kelly E, Healthcare, Compliance and Government Investigations Attorney, Bass, Berry & Sims Josh Stein, CEO & CO Founder, AdhereTech Darin Oppenheimer, (Regulatory Affairs Expert, Global Medical Product Regulations & Licensure Authority, Strategic & Engaging Leader, Baxter Healthcare Corporation) Tom Loker, (Businessman | Author | Speaker, Startup Consultant and Advisor SYDK.ORG, Contributor to California Political Review) Terri Jollymour, Senior Director, Corporate Q&C Strategy, Operations Readiness & Convergence, Johnson & Johnson Dr. Ron Weissman, (Chairman, Software SIG, Band of Angels) Nikolaos Tezapsidis, PhD, President & CEO, Neurotez, Inc Mark Faupel, CEO, Guided Therapeutics inc. Rajesh K. Gupta, Visionary Scientific & Compliance Consultant, Biologics Quality & Regulatory Consultants, LLC (Ex-FDA Official) - Angela Bazigos, (CCO Morf Media Inc)
- Nanda Subbarao, Senior Consultant, Biologics Consulting Group
- Amir Handzel, Science Director, AstraZeneca
- Joseph Gulfo, Executive Director, Rothman Institute of Innovation and Entrepreneurship
- Kari K Loser, Senior Director & Senior Compliance Counsel, Jazz Pharmaceuticals
- Norma (Kirschner) Skolnik, Regulatory Consultant, EAS Consulting Group
|
|